|
1
|
Domènech E, Grífols JR, Akbar A and
Dignass AU: Use of granulocyte/monocytapheresis in ulcerative
colitis: A practical review from a European perspective. World J
Gastroenterol. 27:908–918. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kanekura T: Clinical and immunological
effects of adsorptive myeloid lineage leukocyte apheresis in
patients with immune disorders. J Dermatol. 45:943–950.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kanekura T, Hiraishi K, Kawahara K,
Maruyama I and Kanzaki T: Granulocyte and monocyte adsorption
apheresis (GCAP) for refractory skin diseases caused by activated
neutrophils and psoriatic arthritis: Evidence that GCAP removes
Mac-1-expressing neutrophils. Ther Apher Dial. 10:247–256.
2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen XL, Mao JW and Wang YD: Selective
granulocyte and monocyte apheresis in inflammatory bowel disease:
Its past, present and future. World J Gastrointest Pathophysiol.
11:43–56. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cuadrado E: Granulocyte/monocyte apheresis
as immunotherapic tool: Cellular adsorption and immune modulation.
Autoimmun Rev. 8:292–296. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hanai H, Takeda Y, Eberhardson M, Gruber
R, Saniabadi AR, Winqvist O and Lofberg R: The mode of actions of
the Adacolumn therapeutic leucocytapheresis in patients with
inflammatory bowel disease: A concise review. Clin Exp Immunol.
163:50–58. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yokoyama Y, Fukunaga K, Fukuda Y, Tozawa
K, Kamikozuru K, Ohnishi K, Kusaka T, Kosaka T, Hida N, Ohda Y, et
al: Demonstration of low-regulatory CD25High+CD4+ and
high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with
ulcerative colitis: Modified by selective granulocyte and monocyte
adsorption apheresis. Dig Dis Sci. 52:2725–2731. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nishise S, Abe Y, Nomura E, Sato T, Sasaki
Y, Iwano D, Yoshizawa K, Yagi M, Sakuta K and Ueno Y: Effect of
cellulose acetate beads on interleukin-23 release. Ther Apher Dial.
20:354–359. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rodríguez-Lago I, Benítez JM,
García-Sánchez V, Gutiérrez A, Sempere L, Ginard D, Barreiro-de
Acosta M and Cabriada JL: Granulocyte and monocyte apheresis in
inflammatory bowel disease: The patients' point of view.
Gastroenterol Hepatol. 41:423–431. 2018.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
10
|
Tominaga K, Nakano M, Hoshino M, Kanke K
and Hiraishi H: Efficacy, safety and cost analyses in ulcerative
colitis patients undergoing granulocyte and monocyte adsorption or
receiving prednisolone. BMC Gastroenterol. 13(41)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Panés J, Guilera M, Ginard D, Hinojosa J,
González-Carro P, González-Lara V, Varea V, Domènech E and Badia X:
Treatment cost of ulcerative colitis is apheresis with Adacolumn
cost-effective? Dig Liver Dis. 39:617–625. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yoshino T, Nakase H, Matsuura M, Matsumura
K, Honzawa Y, Fukuchi T, Watanabe K, Murano M, Tsujikawa T,
Fukunaga K, et al: Effect and safety of granulocyte-monocyte
adsorption apheresis for patients with ulcerative colitis positive
for cytomegalovirus in comparison with immunosuppressants.
Digestion. 84:3–9. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Filosa A and Filosa G: Neutrophilic
dermatoses: A broad spectrum of disease. G Ital Dermatol Venereol.
153:265–272. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nelson CA, Stephen S, Ashchyan HJ, James
WD, Micheletti RG and Rosenbach M: Neutrophilic dermatoses:
Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis,
and Behçet disease. J Am Acad Dermatol. 79:987–1006.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. N Engl J Med. 61:496–509. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Krueger JG and Bowcock A: Psoriasis
pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis.
64 (Suppl 2):ii30–ii36. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shindo E, Shikano K, Kawazoe M, Yamamoto
T, Kusunoki N, Hashimoto Y and Nanki T: A case of generalized
pustular psoriasis caused by hydroxychloroquine in a patient with
systemic lupus erythematosus. Lupus. 28:1017–1020. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hoegler KM, John AM, Handler MZ and
Schwartz RA: Generalized pustular psoriasis: A review and update on
treatment. J Eur Acad Dermatol Venereol. 32:1645–1651.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Navarini AA, Burden AD, Capon F, Mrowietz
U, Puig L, Köks S, Kingo K, Smith C and Barker JN: ERASPEN Network.
European consensus statement on phenotypes of pustular psoriasis. J
Eur Acad Dermatol Venereol. 31:1792–1799. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kanekura T, Yoshii N, Yonezawa T, Kawabata
H, Saruwatari H and Kanzaki T: Treatment of pustular psoriasis with
granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol.
49:329–332. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ohnishi H, Kadowaki T, Mizutani Y, Nishida
E, Tobita R, Abe N, Yamaguchi Y, Eto H, Honma M, Kanekura T, et al:
Genetic background and therapeutic response in generalized pustular
psoriasis patients treated with granulocyte and monocyte adsorption
apheresis. Eur J Dermatol. 28:108–11. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sawada K, Ohdo M, Ino T, Nakamura T,
Numata T, Shibata H, Sakou J, Kusada M and Hibi T: Safety and
tolerability of nafamostat mesilate and heparin as anticoagulants
in leukocytapheresis for ulcerative colitis: Post Hoc analysis of a
large-scale, prospective, observational study. Ther Apher Dial.
20:197–204. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shukuya R, Hasegawa T, Niwa Y, Okuma K and
Ikeda S: Granulocyte and monocyte adsorption apheresis for
generalized pustular psoriasis. J Dermatol. 38:1130–1134.
2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sugiura K: The genetic background of
generalized pustular psoriasis: IL36RN mutations and CARD14
gain-of-function variants. J Dermatol Sci. 74:187–192.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Suzuki A, Haruna K, Mizuno Y, Kuwae Y, Ono
Y, Okumura K, Negi O, Kon Y, Takeuchi K, Takamori K, et al:
Successful treatment of three cases of generalized pustular
psoriasis with granulocyte and monocyte adsorption apheresis. Ther
Apher Dial. 16:445–448. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mizutani Y, Fujii K, Kawamura M, Inoue M,
Mizutani YH, Matsuyama K, Doi T, Nagaya S and Seishima M: Intensive
granulocyte and monocyte adsorption apheresis for generalized
pustular psoriasis. J Dermatol. 47:1326–1329. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fujii A, Ohnishi H and Seishima M:
Generalized pustular psoriasis with IL-36 Receptor antagonist
mutation successfully treated with granulocyte and monocyte
adsorption apheresis accompanied by reduced serum IL-6 level. Ther
Apher Dial. 22:92–93. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sakanoue M, Takeda K, Kawai K and Kanekura
T: Granulocyte and monocyte adsorption apheresis for refractory
skin diseases due to activated neutrophils, psoriasis, and
associated arthropathy. Ther Apher Dial. 17:477–483.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ikeda S, Takahashi H, Suga Y, Eto H, Etoh
T, Okuma K, Takahashi K, Kanbara T, Seishima M, Morita A, et al:
Therapeutic depletion of myeloid lineage leukocytes in patients
with generalized pustular psoriasis indicates a major role for
neutrophils in the immunopathogenesis of psoriasis. J Am Acad
Dermatol. 68:609–617. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Fujii A, Fujii K and Seishima M:
Generalized pustular psoriasis with CARD14 Variant c.526G>C
(p.Asp176His) successfully treated with granulocyte and monocyte
adsorption apheresis. Ther Apher Dial. 23:298–299. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Koike Y, Okubo M, Kiyohara T, Fukuchi R,
Sato Y, Kuwatsuka S, Takeichi T, Akiyama M, Sugiura K and Utani A:
Granulocyte and monocyte apheresis can control juvenile generalized
pustular psoriasis with mutation of IL36RN. Br J Dermatol.
177:1732–1736. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Fujisawa T, Moriya C, Shibuya Y, Kanoh H
and Seishima M: Combination therapy of infliximab and
granulocyte/monocyte adsorption apheresis for refractory pustular
psoriasis with psoriatic arthritis. Acta Derm Venereol. 93:364–365.
2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tominaga C, Yamamoto M, Imai Y and
Yamanishi K: A case of old age-onset generalized pustular psoriasis
with a deficiency of IL-36RN (DITRA) treated by granulocyte and
monocyte apheresis. Case Rep Dermatol. 7:29–35. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fujisawa T, Murase K, Okumura Y, Kanoh H,
Doi T, Yoshida S, Ogura S and Seishima M: Generalized pustular
psoriasis successfully treated with granulocyte and monocyte
adsorption apheresis. Ther Apher Dial. 15:374–378. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Fujisawa T, Suzuki S, Mizutani Y, Doi T,
Yoshida S, Ogura S and Seishima M: Granulocyte and monocyte
adsorption apheresis for generalized pustular psoriasis:
Therapeutic outcomes in three refractory patients. Ther Apher Dial.
19:336–341. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Furusawa K, Hasegawa T and Ikeda S:
Immunosuppressant and infliximab-resistant generalized pustular
psoriasis successfully treated with granulocyte and monocyte
adsorption apheresis. Ther Apher Dial. 16:379–380. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mabuchi T, Manabe Y, Yamaoka H, Ota T,
Kato M, Ikoma N, Kusakabe Y, Komaba H and Ozawa A: Case of
generalized pustular psoriasis with end-stage renal disease
successfully treated with granulocyte monocyte apheresis in
combination with hemodialysis. J Dermatol. 41:521–524.
2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Seishima M, Mizutani Y, Shibuya Y,
Nagasawa C and Aoki T: Efficacy of granulocyte and monocyte
adsorption apheresis for pustular psoriasis. Ther Apher Dial.
12:13–18. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sugiura K, Haruna K, Suga Y and Akiyama M:
Generalized pustular psoriasis caused by deficiency of
interleukin-36 receptor antagonist successfully treated with
granulocyte and monocyte adsorption apheresis. J Eur Acad Dermatol
Venereol. 28:1835–1836. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Maverakis E, Marzano AV, Le ST, Callen JP,
Brüggen MC, Guenova E, Dissemond J, Shinkai K and Langan SM:
Pyoderma gangrenosum. Nat Rev Dis Primers. 6(81)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ahronowitz I, Harp J and Shinkai K:
Etiology and management of pyoderma gangrenosum: A comprehensive
review. Am J Clin Dermatol. 13:191–211. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Alavi A, French LE, Davis MD, Brassard A
and Kirsner RS: Pyoderma Gangrenosum: An update on pathophysiology,
diagnosis and treatment. Am J Clin Dermatol. 18:355–372.
2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Russo I, Miotto S, Colpo A, Marson P,
Tison T, Ferrazzi A and Alaibac M: Successful treatment of pyoderma
gangrenosum with granulocyte and monocyte adsorption apheresis. Int
Wound J. 14:282–284. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Higashi Y, Ibusuki A, Baba N, Hatanaka M,
Tada KI and Kanekura T: Granulocyte and monocyte adsorptive
apheresis for pyoderma gangrenosum. Ther Apher Dial. 26:450–455.
2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ikeda K, Hamada T, Otsuka M and Iwatsuki
K: Beneficial effects of neutrophil-targeted therapy for pyoderma
gangrenosum associated with ulcerative colitis. Eur J Dermatol.
21:804–805. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ohmori T, Yamagiwa A, Nakamura I,
Nishikawa K and Saniabadi AR: Treatment of pyoderma gangrenosum
associated with Crohn's disease. Am J Gastroenterol. 98:2101–2102.
2003.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ishikawa H, Kumano T, Suzuki Y, Mabe K,
Suzuki T, Momma S and Momma T: A case of successful treatment with
granulocytapheresis (GCAP) for pyoderma gangrenosum complicating
ulcerative colitis. Jap J Clin Dermatol. 58:1099–1101. 2004.
|
|
48
|
Yoneda K, Chino Y, Kamei K, Yamada T,
Nagura K and You M: Four Cases of pyoderma gangrenosum associated
with ulcerative colitis. Jap J Clin Dermatol. 59:263–266. 2005.
|
|
49
|
Yanaru-Fujisawa R, Matsumoto T, Nakamura
S, Kochi S, Iida M, Kohda F, Hirahashi M, Yao T and Mibu R:
Granulocyte apheresis for pouchitis with arthritis and pyoderma
gangrenosum after restorative proctocolectomy for ulcerative
colitis: A case report. Inflamm Bowel Dis. 11:780–781.
2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Seishima M, Mizutani Y, Shibuya Y,
Nagasawa C and Aoki T: Efficacy of granulocyte and monocyte
adsorption apheresis for three cases of refractory pyoderma
gangrenosum. Ther Apher Dial. 11:177–182. 2007.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Fujino Y, Suzuki Y, Kohama R, Omoya T,
Kitazoe K, Nakamoto J, Aoki H, Yano M, Sikiji T and Satake N: A
case of Pyoderma Gangrenosum successfully treated by
granulocytapheresis and steroid therapy. Tokushima J Med. 30:29–32.
2008.
|
|
52
|
Kawakami T, Yamazaki M and Soma Y:
Reduction of interleukin-6, interleukin-8, and
anti-phosphatidylserine-prothrombin complex antibody by granulocyte
and monocyte adsorption apheresis in a patient with pyoderma
gangrenosum and ulcerative colitis. Am J Gastroenterol.
104:2363–2364. 2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Doi R, Haga T, Fujita A, Saito C, Takeuchi
S, Matsuoka A, Kawakami T, Soma Y and Kouro T: Rinsho Derma.
52:585–587. 2010.
|
|
54
|
Kobayashi S, Takeshita T and Furue M: A
case of Pyoderma Gangrenosum with Ulcerative Colitis successfully
treated with Granulocytapheresis, Skin grafting and Steroid
therapy. Nishi Nihon Hifuka. 73:474–477. 2011.
|
|
55
|
Ohno M, Koyama S, Ohara M, Shimamoto K,
Kobayashi Y, Nakamura F, Mitsuru K and Andoh A: Pyoderma
gangrenosum with ulcerative colitis successfully treated by the
combination of granulocyte and monocyte adsorption apheresis and
corticosteroids. Intern Med. 55:25–30. 2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Okada M, Okawa T, Takashima R and
Higashiyama M: A case of successful treatment with
granulocytapheresis for pyoderma gangrenosum complicating
ulcerative colitis. Skin Research. 16:150–154. 2017.
|
|
57
|
Yamashita A, Nakayama C, Tashiro J and
Miwa J: Ulcerative colitis accompanied by pyoderma gangrenosum
successfully treated with granulocyte monocyte apheresis: A case
report. Prog Dig Endosc. 90:130–131. 2017.
|
|
58
|
Tominaga K, Kamimura K, Sato H, Ko M,
Kawata Y, Mizusawa T, Yokoyama J and Terai S: Cytapheresis for
pyoderma gangrenosum associated with inflammatory bowel disease: A
review of current status. World J Clin Cases. 8:2092–2101.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Shibuya T, Haga K, Saeki M, Haraikawa M,
Tsuchihashi H, Okahara K, Nomura O, Fukushima H, Murakami T,
Ishikawa D, et al: Pyoderma gangrenosum in an ulcerative colitis
patient during treatment with vedolizumab responded favorably to
adsorptive granulocyte and monocyte apheresis. J Clin Apher.
35:488–492. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Kanekura T, Kawahara K, Maruyama I and
Kanzaki T: Treatment of pyoderma gangrenosum with granulocyte and
monocyte adsorption apheresis. Ther Apher Dial. 9:292–296.
2005.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kanekura T, Maruyama I and Kanzaki T:
Granulocyte and monocyte adsorption apheresis for pyoderma
gangrenosum. J Am Acad Dermatol. 47:320–321. 2002.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Kawai M, Kawanami C, Fukuda A and Seno H:
Pyoderma gangrenosum with primary sclerosing cholangitis-associated
colitis successfully treated with concomitant granulocyte and
monocyte adsorption apheresis with corticosteroids. Clin J
Gastroenterol. 14:1561–1566. 2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Murakami M and Terui T: Palmoplantar
pustulosis: Current understanding of disease definition and
pathomechanism. J Dermatol Sci. 98:13–19. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Mrowietz U, Bachelez H, Burden AD, Rissler
M, Sieder C, Orsenigo R and Chaouche-Teyara K: Secukinumab for
moderate-to-severe palmoplantar pustular psoriasis: Results of the
2PRECISE study. J Am Acad Dermatol. 80:1344–1352. 2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Fujisawa T, Tawada C, Mizutani Y, Doi T,
Yoshida S, Ogura S and Seishima M: Efficacy of granulocyte and
monocyte adsorption apheresis for treatment of palmoplantar
pustulosis. Ther Apher Dial. 18:238–243. 2014.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Kawakami H, Nagaoka Y, Hirano H, Matsumoto
Y, Abe N, Tsuboi R, Kanno Y and Okubo Y: Evaluation of the efficacy
of granulocyte and monocyte adsorption apheresis on skin
manifestation and joint symptoms of patients with pustulotic
arthro-osteitis. J Dermatol. 46:144–148. 2019.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Kanekura T, Kawabata H, Maruyama I and
Kanzaki T: Treatment of psoriatic arthritis with granulocyte and
monocyte adsorption apheresis. J Am Acad Dermatol. 50:242–246.
2004.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Bulur I and Onder M: Behçet disease: New
aspects. Clin Dermatol. 35:421–434. 2017.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Tong B, Liu X, Xiao J and Su G:
Immunopathogenesis of Behcet's Disease. Front Immunol.
10(665)2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Alpsoy E, Zouboulis CC and Ehrlich GE:
Mucocutaneous lesions of Behcet's disease. Yonsei Med J.
48:573–585. 2007.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Higashi Y, Shimokawa M, Kawai K and
Kanekura T: Granulocyte and monocyte adsorption apheresis for
Behçet's disease in a pregnant woman. J Dermatol. 40:1042–1044.
2013.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Kanekura T, Gushi A, Iwata M, Fukumaru S,
Sakamoto R, Kawahara K, Maruyama I and Kanzaki T: Treatment of
Behçet's disease with granulocyte and monocyte adsorption
apheresis. J Am Acad Dermatol. 51 (2 Suppl):S83–S87.
2004.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Villarreal-Villarreal CD, Ocampo-Candiani
J and Villarreal-Martínez A: Sweet Syndrome: A review and update.
Actas Dermosifiliogr. 107:369–378. 2016.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
74
|
Cohen PR: Sweet's syndrome-a comprehensive
review of an acute febrile neutrophilic dermatosis. Orphanet J Rare
Dis. 2(34)2007.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Fujii A, Mizutani Y, Hattori Y, Takahashi
T, Ohnishi H, Yoshida S and Seishima M: Sweet's syndrome
successfully treated with granulocyte and monocyte adsorption
apheresis. Case Rep Dermatol. 9:13–18. 2017.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Gerfaud-Valentin M, Jamilloux Y, Iwaz J
and Sève P: Adult-onset Still's disease. Autoimmun Rev. 13:708–722.
2014.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Giacomelli R, Ruscitti P and Shoenfeld Y:
A comprehensive review on adult onset Still's disease. J Autoimmun.
93:24–26. 2018.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Kanekura T, Terasaki K, Higashi Y, Yoshii
N, Kawahara K, Maruyama I and Kanzaki T: Improvement of adult
Still's disease with granulocyte and monocyte adsorption apheresis.
Clin Exp Dermatol. 29:410–412. 2004.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Iwasaki A, Kawakami H and Okubo Y:
Granulocyte/Monocyte adsorption apheresis as a novel therapeutic
approach in the treatment of an impetigo herpetiformis case. Ther
Apher Dial. 22:414–416. 2018.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Namazi N and Dadkhahfar S: Impetigo
herpetiformis: Review of pathogenesis, complication, and treatment.
Dermatol Res Pract. 2018(5801280)2018.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Fujii K, Takahashi T, Matsuyama K, Fujii
A, Mizutani Y, Ohnishi H and Seishima M: Impetigo herpetiformis
with a CARD14 Thr79Ile variant successfully treated with
granulocyte and monocyte adsorption apheresis. J Dermatol.
47:e84–e85. 2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Saito-Sasaki N, Izu K, Sawada Y, Hino R,
Nakano R, Shimajiri S, Nishimura I, Nakamura H, Sugiura K and
Nakamura M: Impetigo herpetiformis complicated with intrauterine
growth restriction treated successfully with granulocyte and
monocyte apheresis. Acta Derm Venereol. 97:410–411. 2017.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Selmi C and Gershwin ME: Diagnosis and
classification of reactive arthritis. Autoimmun Rev. 13:546–549.
2014.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Wu IB and Schwartz RA: Reiter's syndrome:
the classic triad and more. J Am Acad Dermatol. 59:113–121.
2008.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Yoshifuku A, Oyama K, Ibusuki A, Kawasaki
M, Sakanoue M, Matsushita S, Kawai K, Kawahara K, Maruyama I and
Kanekura T: Granulocyte and monocyte adsorption apheresis as an
effective treatment for Reiter disease. Clin Exp Dermatol.
37:241–244. 2012.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Braun-Falco M, Kovnerystyy O, Lohse P and
Ruzicka T: Pyoderma gangrenosum, acne, and suppurative hidradenitis
(PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome.
J Am Acad Dermatol. 66:409–415. 2012.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Cugno M, Borghi A and Marzano AV: PAPA,
PASH and PAPASH Syndromes: Pathophysiology, presentation and
treatment. Am J Clin Dermatol. 18:555–562. 2017.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Hatanaka M, Fujii K and Kanekura T:
Successful treatment of pyoderma gangrenosum, acne, and suppurative
hidradenitis syndrome with granulocyte and monocyte adsorption
apheresis. J Dermatol. 48:376–377. 2021.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Mizutani Y, Okano T, Takahashi T, Ohnishi
H, Ohara O, Sano A and Seishima M: Pyoderma gangrenosum, acne and
suppurative hidradenitis syndrome treated with granulocyte and
monocyte adsorption apheresis. Acta Derm Venereol. 97:275–276.
2017.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Tosca N and Stratigos JD: Possible
pathogenetic mechanisms in allergic cutaneous vasculitis. Int J
Dermatol. 27:291–296. 1988.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Chen KR and Carlson JA: Clinical approach
to cutaneous vasculitis. Am J Clin Dermatol. 9:71–92.
2008.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Goeser MR, Laniosz V and Wetter DA: A
practical approach to the diagnosis, evaluation, and management of
cutaneous small-vessel vasculitis. Am J Clin Dermatol. 15:299–306.
2014.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Kanekura T, Yoshii N, Kawahara K, Maruyama
I and Kanzaki T: Granulocyte and monocyte adsorption apheresis for
cutaneous allergic vasculitis. Ther Apher Dial. 10:287–290.
2006.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Kiriakidou M and Ching CL: Systemic lupus
erythematosus. Ann Intern Med. 172:ITC81–ITC96. 2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Fortuna G and Brennan MT: Systemic lupus
erythematosus: Epidemiology, pathophysiology, manifestations, and
management. Dent Clin North Am. 57:631–655. 2013.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Kanekura T, Hashiguchi T, Mera Y, Katahira
A, Nakamura I, Maruyama I and Kanzaki T: Improvement of SLE skin
rash with granulocyte and monocyte adsorption apheresis.
Dermatology. 208:79–80. 2004.PubMed/NCBI View Article : Google Scholar
|
